HUMAN HERPESVIRUS 8 INFECTION

HUMAN HERPESVIRUS 8 INFECTION was reported 609 times

HUMAN HERPESVIRUS 8 INFECTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Selective T Cell Costimulation Blocker [EPC] 17 0.0036
1 Cytomegalovirus pUL97 Kinase Inhibitor [EPC] 8 0.0032
2 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 59 0.0026
3 Antimalarial [EPC] 11 0.0011
4 Antiprotozoal [EPC] 11 0.0010
5 Antimetabolite Immunosuppressant [EPC] 22 0.0010
6 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 8 0.0006
7 Purine Antimetabolite [EPC] 52 0.0005
8 Nucleoside Analog Antiviral [EPC] 41 0.0005
9 Lipid-based Polyene Antifungal [EPC] 6 0.0005
10 Calcineurin Inhibitor Immunosuppressant [EPC] 46 0.0004
11 Human Immunoglobulin G [EPC] 7 0.0003
12 Corticosteroid [EPC] 413 0.0003
13 Somatostatin Analog [EPC] 2 0.0003
14 Topoisomerase Inhibitor [EPC] 22 0.0003
15 Alkylating Drug [EPC] 59 0.0002
16 beta Lactamase Inhibitor [EPC] 1 0.0002
17 Integrin Receptor Antagonist [EPC] 17 0.0002
18 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 9 0.0002
19 CD20-directed Cytolytic Antibody [EPC] 56 0.0002
20 Penem Antibacterial [EPC] 6 0.0002
21 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 4 0.0002
22 Polyene Antifungal [EPC] 6 0.0001
23 Folate Analog Metabolic Inhibitor [EPC] 64 0.0001
24 Kinase Inhibitor [EPC] 81 0.0001
25 Interleukin-17A Antagonist [EPC] 5 0.0001
26 Interleukin-1 Receptor Antagonist [EPC] 2 0.0001
27 Lipopeptide Antibacterial [EPC] 1 0.0001
28 Azole Antifungal [EPC] 16 0.0001
29 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 11 0.0001
30 Glycopeptide Antibacterial [EPC] 6 0.0001
31 Aminosalicylate [EPC] 9 0.0001
32 Nucleoside Metabolic Inhibitor [EPC] 24 0.0001
33 Antimycobacterial [EPC] 2 0.0001
34 Asparagine-specific Enzyme [EPC] 1 0.0001
35 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 7 0.0001
36 Microtubule Inhibitor [EPC] 11 0.0001
37 Proteasome Inhibitor [EPC] 7 0.0001
38 Platinum-based Drug [EPC] 16 0.0001
39 Janus Kinase Inhibitor [EPC] 9 0.0001
40 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
41 Dihydropyridine Calcium Channel Blocker [EPC] 15 0.0000
42 Nitroimidazole Antimicrobial [EPC] 3 0.0000
43 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 5 0.0000
44 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 5 0.0000
45 Fluoroquinolone Antibacterial [EPC] 5 0.0000
46 Alkaloid [EPC] 1 0.0000
47 Leukocyte Growth Factor [EPC] 5 0.0000
48 Xanthine Oxidase Inhibitor [EPC] 6 0.0000
49 Antidote [EPC] 2 0.0000
50 Interleukin-6 Receptor Antagonist [EPC] 4 0.0000
51 Tetracycline-class Drug [EPC] 2 0.0000
52 Protease Inhibitor [EPC] 1 0.0000
53 Factor Xa Inhibitor [EPC] 6 0.0000
54 Tumor Necrosis Factor Blocker [EPC] 19 0.0000
55 Antirheumatic Agent [EPC] 2 0.0000
56 P2Y12 Platelet Inhibitor [EPC] 2 0.0000
57 Cytochrome P450 3A Inhibitor [EPC] 1 0.0000
58 Opioid Agonist [EPC] 3 0.0000
59 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
60 beta-Adrenergic Blocker [EPC] 3 0.0000
61 Thalidomide Analog [EPC] 5 0.0000
62 Angiotensin 2 Receptor Blocker [EPC] 3 0.0000
63 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
64 Insulin Analog [EPC] 4 0.0000
65 Loop Diuretic [EPC] 4 0.0000
66 Retinoid [EPC] 2 0.0000
67 alpha-Adrenergic Blocker [EPC] 1 0.0000
68 Vitamin D [EPC] 2 0.0000
69 Vitamin B12 [EPC] 2 0.0000
70 Vitamin C [EPC] 2 0.0000
71 Atypical Antipsychotic [EPC] 2 0.0000
72 Platelet Aggregation Inhibitor [EPC] 2 0.0000
73 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
74 Proton Pump Inhibitor [EPC] 1 0.0000
75 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000